相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clopidogrel Resistance is Associated with Long-Term Thrombotic Events in Patients Implanted with Drug-Eluting Stents
Lin Wang et al.
Drugs in research & development (2013)
High on Treatment Platelet Reactivity
Omar Ait-Mokhtar et al.
HEART LUNG AND CIRCULATION (2012)
Platelet function monitoring in patients on clopidogrel: What should we learn from GRAVITAS?
Daniel Aradi et al.
PLATELETS (2012)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
Pharmacogenomic testing: Relevance in medical practice Why drugs work in some patients but not in others
Joseph P. Kitzmiller et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2011)
Modifying Clopidogrel Maintenance Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Improves Clinical Outcome in Patients With Clopidogrel Resistance
Xiao-dong Wang et al.
CLINICAL CARDIOLOGY (2011)
Differential Impacts of CYP2C19 Gene Polymorphisms on the Antiplatelet Effects of Clopidogrel and Ticlopidine
A. Maeda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Paraoxonase 1 (PON1) Gene Variants Are Not Associated With Clopidogrel Response
J. P. Lewis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
S. A. Scott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis
J. Greenhalgh et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI
Guido Parodi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events A Systematic Review and Meta-analysis
Michael V. Holmes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Clopidogrel-Drug Interactions
Eric R. Bates et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Determinants of Quality of Life After Stroke in China The ChinaQUEST (QUality Evaluation of Stroke care and Treatment) Study
Candice Delcourt et al.
STROKE (2011)
An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasma
Gilles Tuffal et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
Tim Bauer et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Risk of Adverse Outcomes in Taiwan Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors in Patients Who Received Percutaneous Coronary Intervention
Chin-Chou Huang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel
Dirk Sibbing et al.
EUROPEAN HEART JOURNAL (2010)
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study
Ankie M. Harmsze et al.
EUROPEAN HEART JOURNAL (2010)
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition
Thomas Gremmel et al.
HEART (2010)
Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation
Ankie Harmsze et al.
PHARMACOGENETICS AND GENOMICS (2010)
Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients
Laurent Bonello et al.
THROMBOSIS RESEARCH (2010)
Clopidogrel Resistance in Japanese Patients Scheduled for Percutaneous Coronary Intervention
Kozo Hoshino et al.
CIRCULATION JOURNAL (2009)
Gastrointestinal Complications After 3 Months of Dual Antiplatelet Therapy for Drug-eluting Stents as Assessed by Wireless Capsule Endoscopy
Ali Seddighzadeh et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2009)
Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene
Peter Staritz et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The safety and efficacy of clopidogrel versus ticlopidine in Japanese stroke patients: combined results of two Phase III, multicenter, randomized clinical trials
Shinichiro Uchiyama et al.
JOURNAL OF NEUROLOGY (2009)
Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
Dirk Sibbing et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Optimizing clopidogrel therapy before stent implantation:: Should clinical setting be taken into account?
Daneil Aradi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Adjusting clopidogrel loading doses according to vasodilator-stimulated phosphoprotein index: On time, too early, or too late?
Thomas Cuisset et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin
Martine Gilard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K. Umemura et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: A potential antiplatelet therapeutic target
Paul A. Gurbel et al.
PLATELETS (2008)
Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects
Nagy A. Farid et al.
PHARMACOTHERAPY (2008)
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
J. T. Brandt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Platelet function monitoring in patients with coronary artery disease
Paul A. Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Clopidogrel resistance: Role of body mass and concomitant medications
Gergely Feher et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events
L. Bonello et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Impact of P-glycoprotein on clopidogrel absorption
Dirk Taubert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
Tobias Geisler et al.
EUROPEAN HEART JOURNAL (2006)
Resistance to clopidogrel: A review of the evidence
TA Nguyen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Prevalence of stroke among Chinese, Malay, and Indian Singaporeans - A community-based tri-racial cross-sectional survey
N Venketasubramanian et al.
STROKE (2005)
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting
DJ Angiolillo et al.
THROMBOSIS RESEARCH (2005)
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
S Matetzky et al.
CIRCULATION (2004)
Clinical significance of the cytochrome P4502C19 genetic polymorphism
Z Desta et al.
CLINICAL PHARMACOKINETICS (2002)
分享论文
